Integrating medications and brief counseling for alcohol use disorder into hepatology clinics

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot uses implementation facilitation to help hepatology clinicians routinely offer medications for alcohol use disorder (MAUD) together with brief counseling to patients with alcohol-associated liver disease. The intervention focuses on training, workflow changes, and clinician supports within Yale School of Medicine/YNHH hepatology clinics. Success will be measured by changes in MAUD prescribing, counseling delivery, and uptake among eligible patients. The goal is to make integrated AUD care more accessible and practical in liver clinics.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.

Exclusion Criteria:

* Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.

Where it's running

• Yale School of Medicine/Yale-New Haven Health
  New Haven, Connecticut, United States Recruiting

Study contacts

• Principal investigator: Lamia Haque — Yale University
• Study coordinator: Lamia Haque, MD MPH
• Email: lamia.haque@yale.edu
• Phone: (203) 777-0304

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Testing LGG for Alcohol Use Disorder and Liver Injury

  This study is testing if a probiotic called LGG can help people with Alcohol Use Disorder and liver issues drink less and improve their liver health over six months.

  Recruiting Phase 2 University of Louisville · Louisville, Kentucky · NCT05178069

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

  This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

  Recruiting Brandeis University · Detroit, Michigan · NCT07724275

• Path180: a computer-based skills program to help teens reduce alcohol use

  This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.

  Recruiting Brown University · Providence, Rhode Island · NCT07713251

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.